Somatic mutations in the connexin 40 gene (GJA5) in atrial fibrillation

New England Journal of Medicine

Volumn 354, Issue 25, 2006, Pages 2677-2688

  Gollob, Michael H ^a,b   Jones, Douglas L ^b   Krahn, Andrew D ^b   Danis, Lynne ^a   Gong, Xiang Qun ^b   Shao, Qing ^b   Liu, Xiaoqin ^c   Veinot, John P ^a   Tang, Anthony S L ^a   Stewart, Alexandre F R ^a   Tesson, Frederique ^a   Klein, George J ^b   Yee, Raymond ^b   Skanes, Allan C ^b   Guiraudon, Gerard M ^b   Ebihara, Lisa ^c   Bai, Donglin ^b  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONNEXIN 40; GAP JUNCTION PROTEIN; GENOMIC DNA;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA ISOLATION; ELECTROPHYSIOLOGY; FEMALE; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC TRANSFECTION; GERM LINE; GJA5 GENE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART MUSCLE CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MISSENSE MUTATION; MORBIDITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; SOMATIC MUTATION; STAINING; TISSUE SPECIFICITY; WILD TYPE;

ADULT; AGE OF ONSET; AMINO ACID SEQUENCE; ATRIAL FIBRILLATION; BASE SEQUENCE; CELL LINE, TUMOR; CONNEXINS; DNA MUTATIONAL ANALYSIS; FEMALE; GAP JUNCTIONS; HEART ATRIA; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; MUTATION, MISSENSE; NEUROBLASTOMA; SEQUENCE HOMOLOGY; TRANSFECTION;

EID: 33745246602     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa052800     Document Type: Article

References (35)

1. Wolf PA, Abott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991;22:983-8.
2. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998;98:946-52.
3. Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation analysis and implications. Arch Intern Med 1995;155:469-73.
4. Wattigney WA, Mensah GA, Croft JB. Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999: implications for primary prevention. Circulation 2003;108:711-6.
5. Chen YH, Xu SJ, Bendahhou S, et al. KCNQ1 gain-of-function mutation in familial atrial fibrillation. Science 2003;299:251-4.
6. Brugada R, Tapscott T, Czernuszewicz GZ, et al. Identification of a genetic locus for familial atrial fibrillation. N Engl J Med 1997;336:905-11.
7. Ellinor PT, Shin JT, Moore RK, Yoerger DM, MacRae CA. Locus for atrial fibrillation maps to chromosome 6q14-16. Circulation 2003;107:2880-3.
8. Erickson RP. Somatic gene mutation and human disease other than cancer. Mutat Res 2003;543:125-36.
9. Puck JM, Straus SE. Somatic mutations - not just for cancer anymore. N Engl J Med 2004;351:1388-90.
10. Yamaguchi H, Calado RT, Ly H, et al. Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia. N Engl J Med 2005;352:1413-24.
11. Beck JA, Poulter M, Campbell TA, et al. Somatic and germline mosaicism in sporadic early-onset Alzheimer's disease. Hum Mol Genet 2004;13:1219-24.
12. Kanno S, Saffitz JE. The role of myocardial gap junctions in electrical conduction and arrhythmogenesis. Cardiovasc Pathol 2001;10:169-77.
13. Hagendorff A, Schumacher B, Kirchhoff S, Luderitz B, Willecke K. Conduction disturbances and increased atrial vulnerability in connexin40-deficient mice analyzed by transesophageal stimulation. Circulation 1999;99:1508-15.
14. Firouzi M, Ramanna H, Kok B, et al. Association of human connexin40 gene polymorphisms with atrial vulnerability as a risk factor for idiopathic atrial fibrillation. Circ Res 2004;95:e29-e33.
15. Pal JD, Berthoud VM, Beyer EC, Mackay D, Shiels A, Ebihara L. Molecular mechanism underlying a Cx50-linked congenital cataract. Am J Physiol 1999;276:C1443-C1446.
16. Nelis E, Simokovic S, Timmerman V, et al. Mutation analysis of the connexin32 (Cx32) gene in Charcot-Marie-Tooth neuropathy type 1: identification of five new mutations. Hum Mutat 1997;9:47-52.
17. Janssen EA, Kemp S, Hensels GW, et al. Connexin32 gene mutations in X-linked dominant Charcot-Marie-Tooth disease (CMTX1). Hum Genet 1997;99:501-5.
18. Bort S, Nelis E, Timmerman V, et al. Mutational analysis of the MPZ, PMP22, and Cx32 genes in patients of Spanish ancestry with Charcot-Marie-Tooth disease and hereditary neuropathy with liability to pressure palsies. Hum Genet 1997;99:746-54.
19. Shiels A, Mackay D, Ionides A, Berry V, Moore A, Bhattacharya SA. A missense mutation in the human connexin50 gene (GJA8) underlies autosomal dominant "zonular pulverulent" cataract, on chromosome 1q. Am J Hum Genet 1998;62:526-32.
20. Kuntzer T, Dunand M, Schorderet DF, Vallat JM, Hahn AF, Bogousslavsky J. Phenotypic expression of a Pro 87 to Leu mutation in the connexin 32 gene in a large Swiss family with Charcot-Marie-Tooth neuropathy. J Neurol Sci 2003;207:77-86.
21. Bayazit YA, Cable BB, Cataloluk O, et al. GJB2 gene mutations causing familial hereditary deafness in Turkey. Int J Pediatr Otorhinolaryngol 2003;67:1331-5.
22. Krutovskikh V, Yamasaki H. Connexin gene mutations in human genetic diseases. Mutat Res 2000;462:197-207.
23. Dilaveris PE, Gialafos EJ, Sideris SK, et al. Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation. Am Heart J 1998;135:733-8.
24. Lerman BB, Dong B, Stein KM, Markowitz SM, Linden J, Catanzaro DF. Right ventricular outflow tract tachycardia due to a somatic cell mutation in G protein subunit αai2. J Clin Invest 1998;101:2862-8.
25. Gutstein DE, Morely GE, Vaidya D, et al. Heterogeneous expression of gap junction channels in the heart leads to conduction defects and ventricular dysfunction. Circulation 2001;104:1194-9.
26. Valiunas V, Gemel J, Brink PR, Beyer EC. Gap junction channels formed by coexpressed connexin40 and connexin43. Am J Physiol Heart Circ Physiol 2001;281:H1675-H1689.
27. Phelan P, Starich TA. Innexins get into the gap. Bioessays 2001;23:388-96.
28. Barnes TM, Hekimi S. The Caenorhabditis elegans avermectin resistance and anesthetic response gene unc-9 encodes a member of a protein family implicated in electrical coupling of excitable cells. J Neurochem 1997;69:2251-60.
29. Suchyna TM, Xu LX, Gao F, Fourtner CR, Nicholson BJ. Identification of a proline residue as a transduction element involved in voltage gating of gap junctions. Nature 1993;365:847-9.
30. Ri Y, Ballesteros JA, Abrams CK, et al. The role of a conserved proline in mediating conformational changes associated with voltage gating of Cx32 gap junctions. Biophys J 1999;76:2887-98.
31. Cox JL, Canavan TE, Schuessler RB, et al. The surgical treatment of atrial fibrillation. II. Intraoperative electrophysiologic mapping and description of the electrophysiologic basis of atrial flutter and fibrillation. J Thorac Cardiovasc Surg 1991;101:406-26.
32. Konings KT, Kirchhof CJ, Smeets JR, Wellens HJ, Penn OC, Allessie MA. Highdensity mapping of electrically induced atrial fibrillation in humans. Circulation 1994;89:1665-80.
33. Spach MS, Josephson ME. Initiating reentry: the role of nonuniform anisotropy in small circuits. J Cardiovasc Electrophysiol 1994;5:182-209.
34. Coumel P. Role of the autonomic nervous system in paroxysmal atrial fibrillation. In: Waldo AL, Touboul T, eds. Atrial flutter: advances in mechanisms and management. Armonk, N.Y.: Futura Publishing, 1996:248-61.
35. Fritz S, Kunz L, Dimitrijevic N, Grunert R, Heiss C, Mayerhofer A. Muscarinic receptors in human luteinized granulosa cells: activation blocks gap junctions and induces the transcription factor early growth response factor-1. J Clin Endocrinol Metab 2002;87:1362-7.